Despite the recent discoveries of the therapeutic potential of psychedelics for human welfare, the Drug Enforcement Agency announced that it would be adding five variants of these drugs to the harshest drug classification—Schedule 1. This recent move will discourage the growing support for psychedelic research in the country.